Journal of Nuclear Cardiology

, Volume 25, Issue 1, pp 75–83 | Cite as

The severity of ventricular arrhythmia correlates with the extent of myocardial sympathetic denervation, but not with myocardial fibrosis extent in chronic Chagas cardiomyopathy

Chagas disease, denervation and arrhythmia
  • Leonardo Pippa Gadioli
  • Carlos Henrique Miranda
  • Antonio Osvaldo Pintya
  • Alexandre Baldini de Figueiredo
  • André Schmidt
  • Benedito Carlos Maciel
  • José Antonio Marin-Neto
  • Marcus Vinicius SimõesEmail author
Original Article



To investigate the correlation between the extent of myocardial sympathetic denervation and fibrosis and the presence of degrees of severity of ventricular arrhythmias in chronic Chagas cardiomyopathy (CCC).


Forty-three CCC patients with left ventricular ejection fraction (LVEF) ≥ 35% were divided into three groups: SVT group—presenting Sustained Ventricular Tachycardia (SVT) (n = 15), NSVT group—exhibiting episodes of non-SVT (NSVT) on 24-h Holter monitoring (n = 11), and Control group—exhibiting neither SVT nor episodes of NSVT (n = 17). The patients underwent SPECT imaging for myocardial sympathetic innervation with 123Iodine-MIBG (MIBG) and myocardial perfusion with 99mTc-Sestamibi (MIBI) for the evaluation of regional myocardial fibrosis.


The summed rest perfusion scores were similar in the three groups. The summed difference score between MIBG and MPI images, which evaluated the extent of denervated but viable myocardium, was significantly higher in SVT group (20.0 ± 8.0) as compared with the control group (2.0 ± 5.0, P < .0001) and with the NSVT group (11.0 ± 8.0, P < .05).


The occurrence of ventricular arrhythmias of different degrees of severity correlates quantitatively with the extent of cardiac sympathetic denervation, but not with the extent of fibrosis, suggesting that myocardial sympathetic denervation plays a major role in triggering ventricular arrhythmia in CCC.


Chronic Chagas cardiomyopathy myocardial sympathetic denervation myocardial fibrosis ventricular arrhythmias 



Chagas disease


Chronic Chagas cardiomyopathy


Non-sustained ventricular tachycardia


Sustained ventricular tachycardia


Left ventricular ejection fraction




Obstructive coronary artery disease


Myocardial perfusion imaging








Funding Sources

This study was partially funded by FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo) Research Grant No. 2008/04140-3.

Supplementary material

12350_2016_556_MOESM1_ESM.ppt (8.5 mb)
Supplementary material 1 (PPT 8673 kb)


  1. 1.
    Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Sachs SE, Sachs JD, et al Control of neglected tropical diseases. N Engl J Med 2007;357:1018-27.CrossRefPubMedGoogle Scholar
  2. 2.
    Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 2009;49:e52-4.CrossRefPubMedGoogle Scholar
  3. 3.
    Gascon J, Bern C, Pinazo MJ. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop 2010;115:22-7.CrossRefPubMedGoogle Scholar
  4. 4.
    Mendoza I, Moleiro F, Marques J. Sudden death in Chagas’ disease. Arquivos brasileiros de cardiologia 1992;59:3-4.PubMedGoogle Scholar
  5. 5.
    Rassi A Jr, Rassi SG, Rassi A. Sudden death in Chagas’ disease. Arquivos brasileiros de cardiologia 2001;76:75-96.CrossRefPubMedGoogle Scholar
  6. 6.
    Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet 2010;375:1388-402.CrossRefPubMedGoogle Scholar
  7. 7.
    Sarabanda AV, Sosa E, Simoes MV, Figueiredo GL, Pintya AO, Marin-Neto JA. Ventricular tachycardia in Chagas’ disease: A comparison of clinical, angiographic, electrophysiologic and myocardial perfusion disturbances between patients presenting with either sustained or nonsustained forms. Int J Cardiol 2005;102:9-19.CrossRefPubMedGoogle Scholar
  8. 8.
    Miranda CH, Figueiredo AB, Maciel BC, Marin-Neto JA, Simoes MV. Sustained ventricular tachycardia is associated with regional myocardial sympathetic denervation assessed with 123I-metaiodobenzylguanidine in chronic Chagas cardiomyopathy. J Nucl Med 2011;52:504-10.CrossRefPubMedGoogle Scholar
  9. 9.
    Rassi A Jr, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, et al Development and validation of a risk score for predicting death in Chagas’ heart disease. N Engl J Med 2006;355:799-808.CrossRefPubMedGoogle Scholar
  10. 10.
    Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42.CrossRefPubMedGoogle Scholar
  11. 11.
    Flotats A, Carrio I, Agostini D, Le Guludec D, Marcassa C, Schafers M, et al Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging 2010;37:1802-12.CrossRefPubMedGoogle Scholar
  12. 12.
    Hiss FC, Lascala TF, Maciel BC, Marin-Neto JA, Simoes MV. Changes in myocardial perfusion correlate with deterioration of left ventricular systolic function in chronic Chagas’ cardiomyopathy. JACC Cardiovasc Imaging 2009;2:164-72.CrossRefPubMedGoogle Scholar
  13. 13.
    Simoes MV, Pintya AO, Bromberg-Marin G, Sarabanda AV, Antloga CM, Pazin-Filho A, et al Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas’ cardiomyopathy. Am J Cardiol 2000;86:975-81.CrossRefPubMedGoogle Scholar
  14. 14.
    Marin-Neto JA, Marzullo P, Marcassa C, Gallo Junior L, Maciel BC, Bellina CR, et al Myocardial perfusion abnormalities in chronic Chagas’ disease as detected by thallium-201 scintigraphy. Am J Cardiol 1992;69:780-4.CrossRefPubMedGoogle Scholar
  15. 15.
    Medrano R, Lowry RW, Young JB, Weilbaecher DG, Michael LH, Afridi I, et al Assessment of myocardial viability with 99mTc sestamibi in patients undergoing cardiac transplantation. A scintigraphic/pathological study. Circulation 1996;94:1010-7.CrossRefPubMedGoogle Scholar
  16. 16.
    Rochitte CE, Oliveira PF, Andrade JM, Ianni BM, Parga JR, Avila LF, et al Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas’ disease: a marker of disease severity. J Am Coll Cardiol 2005;46:1553-8.CrossRefPubMedGoogle Scholar
  17. 17.
    Mello RP, Szarf G, Schvartzman PR, Nakano EM, Espinosa MM, Szejnfeld D, et al Delayed enhancement cardiac magnetic resonance imaging can identify the risk for ventricular tachycardia in chronic Chagas’ heart disease. Arquivos brasileiros de cardiologia 2012;98:421-30.CrossRefPubMedGoogle Scholar
  18. 18.
    Sosa E, Scanavacca M, d’Avila A, Fukushima J, Jatene A. Long-term results of visually guided left ventricular reconstruction as single therapy to treat ventricular tachycardia associated with postinfarction anteroseptal aneurysm. J Cardiovasc Electrophysiol 1998;9:1133-43.CrossRefPubMedGoogle Scholar
  19. 19.
    Kasama S, Toyama T, Kaneko Y, Iwasaki T, Sumino H, Kumakura H, et al Relationship between late ventricular potentials and myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with dilated cardiomyopathy with mild to moderate heart failure: results of a prospective study of sudden death events. Eur J Nucl Med Mol Imaging 2012;39:1056-64.CrossRefPubMedGoogle Scholar
  20. 20.
    Manco JC, Gallo L Jr, Godoy RA, Fernandes RG, Amorim DS. Degeneration of the cardiac nerves in Chagas’ disease. Further studies. Circulation 1969;40:879-85.CrossRefPubMedGoogle Scholar
  21. 21.
    Amorim DS, Mello de Oliveira JA, Manco JC, Gallo L Jr, Meira de Oliveira JS. Chagas’ heart disease. First demonstrable correlation between neuronal degeneration and autonomic impairment. Acta Cardiol 1973;28:431-40.PubMedGoogle Scholar
  22. 22.
    Marin-Neto JAGJL, Manço JC, Rassi A, Amorim DS. Postural reflexes in chronic Chagas’ heart disease: heart rate and arterial pressure responses. Cardiology 1975;60:343-57.CrossRefGoogle Scholar
  23. 23.
    Oria JRJ. Alterações do metassimpático do coração nos portadores de megaesôfago. Arquivos brasileiros de cardiologia 1949;2:311-6.Google Scholar
  24. 24.
    Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV. Pathogenesis of chronic Chagas heart disease. Circulation 2007;115:1109-23.CrossRefPubMedGoogle Scholar
  25. 25.
    Terai H, Shimizu M, Ino H, Yamaguchi M, Uchiyama K, Oe K, et al Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy. J Nucl Med 2003;44:1612-7.PubMedGoogle Scholar
  26. 26.
    Paul M, Wichter T, Kies P, Gerss J, Wollmann C, Rahbar K, et al Cardiac sympathetic dysfunction in genotyped patients with arrhythmogenic right ventricular cardiomyopathy and risk of recurrent ventricular tachyarrhythmias. J Nucl Med 2011;52:1559-65.CrossRefPubMedGoogle Scholar
  27. 27.
    Paul M, Schafers M, Kies P, Acil T, Schafers K, Breithardt G, et al Impact of sympathetic innervation on recurrent life-threatening arrhythmias in the follow-up of patients with idiopathic ventricular fibrillation. Eur J Nucl Med Mol Imaging 2006;33:866-70.CrossRefPubMedGoogle Scholar
  28. 28.
    Daliento L, Folino AF, Menti L, Zanco P, Baratella MC, Dalla Volta S. Adrenergic nervous activity in patients after surgical correction of tetralogy of Fallot. J Am Coll Cardiol 2001;38:2043-7.CrossRefPubMedGoogle Scholar
  29. 29.
    Mitrani RD, Klein LS, Miles WM, Hackett FK, Burt RW, Wellman HN, et al Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease. J Am Coll Cardiol 1993;22:1344-53.CrossRefPubMedGoogle Scholar
  30. 30.
    Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, et al Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol 2010;55:2769-77.CrossRefPubMedGoogle Scholar
  31. 31.
    Marshall A, Cheetham A, George RS, Mason M, Kelion AD. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts ventricular arrhythmia in heart failure patients receiving an implantable cardioverter-defibrillator for primary prevention. Heart 2012;98:1359-65.CrossRefPubMedGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 2016

Authors and Affiliations

  • Leonardo Pippa Gadioli
    • 1
  • Carlos Henrique Miranda
    • 1
  • Antonio Osvaldo Pintya
    • 1
  • Alexandre Baldini de Figueiredo
    • 1
  • André Schmidt
    • 1
  • Benedito Carlos Maciel
    • 1
  • José Antonio Marin-Neto
    • 1
  • Marcus Vinicius Simões
    • 1
    Email author
  1. 1.Division of Cardiology, Medical School of Ribeirão PretoUniversity of São PauloRibeirão PretoBrazil

Personalised recommendations